Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer.
Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer.
复制标题
设计用于磁共振分子成像引导肺癌治疗诊断的多功能癌症靶向纳米系统
DOI:
10.1080/10717544.2018.1494224
复制
发表时间:
2018-11
期刊:
影响因子:
6
通讯作者:
Luo L
中科院分区:
文献类型:
--
作者:
Gao P;Mei C;He L;Xiao Z;Chan L;Zhang D;Shi C;Chen T;Luo L
The integration of diagnosis and therapy is an effective way to improve therapeutic effects for cancer patients, which has acquired widely attentions from researchers. Herein, a multifunctional drug-loaded nanosystem (F/A-PLGA@DOX/SPIO) has been designed and synthesized to reduce the side effects of traditional chemotherapy drugs and realize simultaneous tumor diagnosis and treatment. The surface modification of folic acid (FA) and activatable cell-penetrating peptide (ACPP) endows the nanosystem with excellent cancer targeting capabilities, thus reducing toxicity to normal organs. Besides, the F/A-PLGA@DOX/SPIO nanosystem can serve as an excellent magnetic resonance imaging (MRI) T2-negative contrast agent. More importantly, according to in vitro experiments, the F/A-PLGA@DOX/SPIO nanosystem can promote the overproduction of reactive oxygen species (ROS) within A549 lung cancer cells, inducing cell apoptosis, greatly enhancing the antineoplastic effect. Furthermore, with the help of MRI technology, the targeting imaging of the F/A-PLGA@DOX/SPIO nanosystem within tumors and the dynamic monitoring of medicine efficacy can be realized. Therefore, this study provided a multifunctional drug-loaded F/A-PLGA@DOX/SPIO targeted nanosystem for magnetic resonance molecular imaging-guided theranostics, which has excellent potential for the application in tumor diagnosis and therapy.
登录
查看更多内容
影响因子:
7.4
作者:
Fan, Cundong;Chen, Jingjing;Chen, Tianfeng
通讯作者:
Chen, Tianfeng
DOI:
10.4274/tjh.2015.0142
发表时间:
2016-03-05
期刊:
Turkish journal of haematology : official journal of Turkish Society of Haematology
影响因子:
--
作者:
İdilman İS;Gümrük F;Haliloğlu M;Karçaaltıncaba M
通讯作者:
Karçaaltıncaba M
影响因子:
14
作者:
He, Lizhen;Lai, Haoqiang;Chen, Tianfeng
通讯作者:
Chen, Tianfeng
DOI:
10.1016/j.jconrel.2012.06.028
发表时间:
2012-08-20
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Fang C;Kievit FM;Veiseh O;Stephen ZR;Wang T;Lee D;Ellenbogen RG;Zhang M
通讯作者:
Zhang M
影响因子:
2.9
作者:
Kim, Hoe Suk;Oh, Sue Young;Moon, Woo Kyung
通讯作者:
Moon, Woo Kyung